(Q37824303)

23 August 2017

1 reference

title

The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease (English)

1 reference

23 August 2017

1 reference

2

Yehuda Shoenfeld

1 reference

23 August 2017

1

Udi Nussinovitch

1 reference

PubMed ID

21188649

23 August 2017

language of work or name

1 reference

1 February 2013

1 reference

Clinical Reviews in Allergy & Immunology

23 August 2017

1 reference

23 August 2017

44

1 reference

23 August 2017

1

1 reference

23 August 2017

75-83

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-010-8228-9

23 August 2017

0 references

cites work

Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Autoimmunity and heart diseases: pathogenesis and diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Recurrent pericarditis: infectious or autoimmune?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Stress as a trigger of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Antioxidants and smoking in autoimmune disease--opposing sides of the seesaw?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Cardiovascular involvement in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Functional autoantibodies, a new paradigm in autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Celiac disease: from gluten to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Autoantibodies as predictors of disease: the clinical and experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Autoimmune mechanisms underlying dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Echocardiographic abnormalities in familial dysautonomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

QT dispersion in uncomplicated familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Autoantibody against cardiac beta1-adrenoceptor induces apoptosis in cultured neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Anti-troponin autoantibodies and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Genetic complexity of autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Anti-beta 1-adrenoreceptor autoantibodies and myocardial sympathetic nerve activity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Evidence for the use of intravenous immunoglobulins--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12016-010-8228-9

21 January 2018

12 December 2020

Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists?

1 reference

12 December 2020

A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor

1 reference

12 December 2020

The mosaic of autoimmunity

1 reference

12 December 2020

Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease

1 reference

12 December 2020

Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis

1 reference

12 December 2020

Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment

1 reference

12 December 2020

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy

1 reference

12 December 2020

Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies

1 reference

12 December 2020

A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure

1 reference

12 December 2020

Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine

1 reference

12 December 2020

Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy

1 reference

12 December 2020

Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis.

1 reference

12 December 2020

Mimicry and antibody-mediated cell signaling in autoimmune myocarditis

1 reference

12 December 2020

Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages

1 reference

12 December 2020

10.1007/S12016-010-8228-9

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21188649